Clinical trial
An Exploratory Clinical Study on the Safety and Efficacy of the Ultrasonic Nerve Ablation System in the Treatment of Essential Hypertension
NCT06877234 is registered in ClinicalTrials.gov with Shenzhen Pulsecare Medical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Clinical Study on the Safety and Efficacy of the Ultrasonic Nerve Ablation System in the Treatment of Essential Hypertension
- Lead sponsor
- Shenzhen Pulsecare Medical Technology Co., Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 8, 2024
- Completion date
- March 31, 2026
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.